Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Mylan releases Fenoglide generic

Mylan N.V. has launched fenofibrate tablets 40 mg and 120 mg, a cholesterol-lowering drug, in the United States. Mylan said Wednesday that its fenofibrate product is a generic version of Fenoglide tablets from Santarus.

PITTSBURGH — Mylan N.V. has launched fenofibrate tablets 40 mg and 120 mg, a cholesterol-lowering drug, in the United States.

Mylan said Wednesday that its fenofibrate product is a generic version of Fenoglide tablets from Santarus.

Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B to increase high-density lipoprotein in adults with primary hypercholesterolemia or mixed dyslipidemia.

U.S. sales of fenofibrate tablets (40 mg and 120 mg) totaled approximately $28.6 million for the 12 months ended April 30, according to IMS Health data reported by Mylan.

Comments

Latest